期刊名称：JOURNAL OF HUMAN HYPERTENSION
 期刊简介(About the journal)
投稿须知(Instructions to Authors)
编辑部信息(Editorial Board)
About the journal
|
The Journal of Human Hypertension is published monthly. The editors will consider for publication all suitable papers dealing directly or indirectly with clinical aspects of hypertension, including epidemiology. The journal aims to perform the dual role of increasing knowledge in the field of high blood pressure as well as improving the standard of care of patients. |
Instructions to Authors
Journal of Human Hypertension considers manuscripts prepared in accordance with the guidelines laid down by the International Committee of Medical Journal Editors (Br Med J 1982, 284: 1766-1770). All material submitted is assumed to be submitted exclusively to Journal of Human Hypertension unless the contrary is stated.
Typescripts Three complete copies should be sent to the Editor, Professor DG Beevers, Journal of Human Hypertension, University Department of Medicine, City Hospital, Dudley Road, Birmingham B18 7QH, UK. Authors in North America may submit manuscripts directly to, Professor FH Messerli, Ochsner Clinic, 1514 Jefferson Highway, New Orleans, LA 70121, USA. Authors in Asia and the Pacific may submit manuscripts directly to: Professor H Ueshima, Shiga University of Medical Science, Department of Health Science, Tsukinowa-cho Seta Otsu, Shiga Prefecture 520-21, Japan. Papers must be type-written, double-spaced, on one side of paper not larger than A4 (297 mm x 210 mm), with a 5 cm margin. The first page of the typescript should bear the names of the author(s) and the name and address of the laboratory or institution where the work has been carried out, in addition to the title of the paper. The full address of the principal author to whom proofs will be sent should be given as a footnote, as should any permanent changes of address and/or appointment. A short (running) title of not more than 45 characters should be given. Three to six keywords must be submitted with the abstract. All papers should be numbered including the title page.
The principal author must ensure that any co-authors listed agree to submission of the typescript. Any written or illustrative material which has been or will be published elsewhere must be duly acknowledged and accompanied by the written consent of the authors and publishers concerned.
Copyright Authors will be asked before publication to assign the world copyright of their manuscript to Nature Publishing Group. Therefore all manuscripts submitted must be accompanied by a signed statement that the article is original, is not under consideration or has not been previously published elsewhere and its contents has not been anticipated by any previous publication. Authors will be entitled to publish any part of their paper elsewhere without permission, provided the usual acknowledgements are given. The assignment of copyright will not affect subsisting patent rights or arrangements relating to them. Submission of a manuscript will be taken to imply that authors have obtained permission from their employers or institution to publish, if they have a contractual or moral obligation to do so.
Arrangement Papers should be divided into: (a) Title page, (b) Summary and Keywords, (c) Introduction, (d) Materials and Methods, (e) Results, (f) Discussion, (g) Acknowledgements, (h) References, (i) Tables, (j) Figures and captions. The summary should not exceed 250 words and should state concisely what was done, the main findings and how the work was interpreted. The three to six keywords for the paper should appear at the end of the summary. Keywords will be used to compile the annual index.
Style Abbreviations and symbols must be standard and SI units used throughout. The following abbreviations are approved: ACE-Angiotensin-converting-enzyme; PRA-Plasma renin activity; PRC-Plasma renin concentration; BP-Blood pressure; SBP-Systolic blood pressure; DBP-Diastolic blood pressure; MAP-Mean arterial pressure; RAS-Renal artery stenosis; RAA System - Renin-angiotensin-aldosterone system and ANP-Arterial natriuretic peptide. Acronyms should be used sparingly and must be fully explained when first used. Whenever possible drugs should be given their approved generic name. Where a proprietary (brand) name must be used, it should begin with a capital letter. Statistical analyses must explain the methods used. The use of footnotes is not permitted. Single quotation marks should be used and words to be italicised should be underlined. The concise Oxford English Dictionary is used as a reference for spelling and hyphenation.
References should follow the Vancouver format. In the text, they should appear as numbers starting at 1. At the end of the paper they should be listed (double-spaced) in numerical order corresponding to the order of citation in the text. All authors should be quoted for papers with up to four authors; for papers with more than four authors, the first one only should be quoted followed by et al. Abbreviations for titles of medical periodicals should conform to those used in the latest edition of Index Medicus. The first and last page numbers for each reference should be provided. Abstracts and letters must be identified as such.
1 Clements R and Gravelle IH. Radiological appearances of hydatid disease in Wales. Postgrad Med J 1986; 62: 167-173.
2 Greenbeerger JS. Long-term hematopoietic cultures. In: Golde, W. (ed) Hematopoiesis. Churchill-Livingstone: New York, 1984, pp 203-242. Figures In the text Arabic numbers should be used and all illustrations should be specifically referred to in the text, eg (Figure 2). All illustrations should be submitted as glossy prints to about 1* times the intended final size and should be numbered as figures whether they are photographs, representational drawings or line diagrams and graphs.
Photographs and photomicrographs should be unmounted glossy prints, should not be retouched, and should be chosen to exclude technical artefacts. Magnification is best indicated by a line representing a defined length included within the photographs. Areas of key interest and/or critical reproduction should be indicated on a flimsy overlay attached to a photograph or on a photocopy. All annotations and lettering should be indicated in the same way, and preferably not included on the original print. Clearly contrasted and focused prints are essential for adequate reproduction.
Line diagrams and graphs should be on separate sheets: they must be drawn with black Indian ink on white paper, or supplied as photographic prints of such originals. Lettering on figures should be minimal and must not duplicate the legend. The use of symbols should be consistent within papers, and explanations of symbols should be included in the caption, not on the figure. A photocopy of all illustrations should be submitted. Tables These should be as few as possible and should present only essential data. They should be typewritten on separate sheets, have a title or caption, and be given Arabic numbers.
Supplementary information
Supplementary information is peer-reviewed material directly relevant to the conclusion of an article that cannot be included in the printed version owing to space or format constraints. It is posted on the journal's web site and linked to the article when the article is published and may consist of data files, graphics, movies or extensive tables.
The printed article must be complete and self-explanatory without the supplementary information. Supplementary information enhances a reader's understanding of the paper but is not essential to that understanding.
Supplementary information must be supplied to the editorial office in its final form for peer review. On acceptance the final version of the peer reviewed supplementary information should submitted with the accepted paper. Supplementary information is not subedited, so authors should ensure that it is supplied ready for publication online.
To ensure that the contents of the supplementary information files can be viewed by the editor(s), referees and readers, please also submit a 'read-me' file containing brief instructions on how to use the file.
The supplementary information may not be altered, nor new supplementary information added, after the paper has been accepted for publication.
Supplying supplementary information files
Please supply the supplementary information via eJP, the electronic manuscript submission and tracking system, in an acceptable file format (see below).
Authors should:
- Include a text summary (no more than 50 words) to describe the contents of each file.
- Identify the types of files (file formats) submitted.
- Include the text 'Supplementary information is available at (the journal's name)'s website' at the end of the article and before the references.
Accepted file formats:
- Quick Time files (.mov)
- graphical image files (.gif)
- HTML files (.html)
- MPEG movie files (.mpg)
- JPEG image files (.jpg)
- sound files (.wav)
- plain ASCII text (.txt)
- Acrobat files (.pdf)
- MS Word documents (.doc)
- Postscript files (.ps)
- MS Excel spreadsheet documents (.xls)
We cannot accept TeX and LaTeX.
File sizes must be as small as possible, so that they can be downloaded quickly. Images should not exceed 640 x 480 pixels (9 x 6.8 inches at 72 pixels per inch) but we would recommend 480 x 360 pixels as the maximum frame size for movies. We would also recommend a frame rate of 15 frames per second. If applicable to the presentation of the supplementary information, use a 256 colour palette. Please consider the use of lower specification for all of these points if the supplementary information can still be represented clearly. Our recommended maximum data rate is 150 KB/s.
The number of files should be limited to eight, and the total file size should not exceed 3 MB. Individual files should not exceed 1 MB. Please seek advice from the editorial office before sending files larger than our maximum size to avoid delays in publication.
Further questions about the submission or preparation of supplementary information should be directed to the editorial office.
Proofs One marked copy of the proofs will be sent to the principal author who should read it carefully for errors. One corrected copy must be returned to the Editor within 3 days. Major alterations to the text cannot be accepted.
Copyright assignment Authors will be asked before publication to assign the world copyright of their manuscript to Macmillan Publishers Ltd. Therefore, all manuscripts submitted must be accompanied by a signed statement that the article is original, is not under consideration or has not been previously published elsewhere and its content has not been anticipated by any previous publication. Authors will be entitled to publish any part of their paper elsewhere without permission, provided the usual acknowledgements are given.
Offprints Twenty-five offprints will be supplied free of charge to the principal author. Additional offprints may be ordered on the form accompanying proofs. The charges are necessarily higher if orders are received after the issue has gone to press.
Drug side effects Manuscripts reporting adverse drug reactions should be accompanied by evidence showing that the reaction has been reported on a 'Yellow card' or to the appropriate drug licensing authority, and to the drug manufacturer.
Business matters
Business correspondence and enquiries relating to advertising, subscriptions, backnumbers or reprints should be addressed to the relevant person at Nature Publishing Group, Houndmills, Basingstoke, Hampshire RG21 6XS, UK.
Editorial Board
Editor-in-Chief
Professor Gareth Beevers
University Department of Medicine
City Hospital
Dudley Rd
Birmingham B18 7QH UK
Tel: +44 121 507 5080
Fax: +44 121 554 4083
Editor for the Americas
Professor Franz Messerli
Ochsner Clinic
1514 Jefferson Highway
New Orleans LA 70121, USA
Tel: +1 504 842 3144 / 4077
Fax: +1 504 842 4220
Editor for Asia and the Pacific
Professor Hirotsugu Ueshima
Shiga University of Medical Science
Department of Health Science
Tsukinowa-cho Seta Otsu
Shiga Prefecture 520-21, Japan
Tel: +81 775 48 2191
Fax: +81 775 43 9732
E-mail: hueshima@sums.shiga-med.ac.jp
Deputy Editor
Dr Gregory Lip
University Department of Medicine
City Hospital
Dudley Rd
Birmingham B18 7QH UK
Tel: +44 121 507 5080
Fax: +44 121 554 4083
|
